Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Safety and efficacy of statins

The 2016 Review by Rory Collins and colleagues (Nov 19, p 2532),1 of evidence about the efficacy and safety of statin therapy, claims that the 2012 Cholesterol Treatment Trialists’ (CTT) meta-analysis shows that “lowering LDL cholesterol by 2 mmol/L (77 mg/dL) with an effective low-cost statin regimen (eg, atorvastatin 40 mg daily) for 5 years in 10 000 patients would typically prevent major vascular events from occurring in…500 patients (ie, 5% absolute benefit) who are at increased risk but have not yet had a vascular event (primary prevention)”.

email